The ins and outs of drug-releasing vaginal rings: a literature review of expulsions and removals
Authors:
- 9 August 2020
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 17 (11) , 1519-1540
Abstract
There is considerable interest in vaginal ring technology for sustained/controlled release of pharmaceutical drugs to the human vagina. Seven drug-releasing vaginal ring products have reached marke...Keywords
This publication has 184 references indexed in Scilit:
- An Evaluation of Polycaprolactone Matrices for Vaginal Delivery of the Antiviral, Tenofovir, in Preventing Heterosexual Transmission of HIVJournal of Pharmaceutical Sciences, 2013
- A 90-Day Tenofovir Reservoir Intravaginal Ring for Mucosal HIV ProphylaxisAntimicrobial Agents and Chemotherapy, 2012
- Safe and Sustained Vaginal Delivery of Pyrimidinedione HIV-1 Inhibitors from Polyurethane Intravaginal RingsAntimicrobial Agents and Chemotherapy, 2012
- A 5‐year prospective study of vaginal pessary use for pelvic organ prolapseInternational Journal of Gynecology & Obstetrics, 2011
- Incontinence pessaries: size, POPQ measures, and successful fittingInternational Urogynecology Journal, 2009
- Biomechanical properties of the vaginal wall: effect of pregnancy, elastic fiber deficiency, and pelvic organ prolapseAmerican Journal of Obstetrics and Gynecology, 2008
- Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapseAmerican Journal of Obstetrics and Gynecology, 2004
- Fertility regulation in nursing womenContraception, 1997
- Studies on a vaginal ring releasing levonorgestrel at an initial rate of 27 μg/24h when used alone or in combination with transdermal systems releasing estradiolContraception, 1994
- Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and D-NorgestrelContraception, 1981